GW Pharmaceuticals announces that Sativex receives fast track designation from FDA in cancer pain

GW Pharmaceuticals plc, a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, has announced that...
Pain / Anesthetics News From Medical News Today

Share:

Related Content